General Information Concerning Patents

whitePaper | January 27, 2020

On September 27, 1998, football fans who tuned in to watch the game between the Baltimore Ravens and the Cincinnati Bengals witnessed much more than a 31-24 Bengal win. That Sunday, ESPN introduced a technological inno-vation that would forever change the way fans watch sports: a thin yellow line overlaid onto live video representing the distance required for a first down.

whitePaper | June 30, 2020

There’s no arguing that preventing failures and accidents is critical for industry. Unexpected incidents can grind operations to a halt for extended periods of time and necessitate expensive repairs. For example, just 12 hours of downtime for an oil production platform could cost six to eight million dollars in lost production opportunity alone. A single day of grounding for a plane costs roughly four to five million dollars. Because of these disruptions, industrial sectors are always on the lookout for newer, better maintenance methods, and the approach on everyone’s lips right now is predictive maintenance.

whitePaper | November 15, 2019

Trade was not such a controversial topic not so long ago. For most of the post-war era trade worked well for the US and for many other countries. A bipartisan consensus supported continuing trade liberalization as long as it was accompanied by full employment. However trade always had winners and losers as economies adjust to different costs of production among trading partners and over the last few decades the number of US workers losing from trade mounted and the losses spread across hard hit communities. For these and other reasons, trade has become so controversial that it is now a key pivot point in politics and elections in the US.

whitePaper | May 15, 2022

Long before the pandemic created a worldwide retreat from physical workplaces, governments around the world recognised the need to undertake a digital transformation of some kind. Many governments had started to build transformation strategies that would support the gradual adoption of digital technologies to improve efficiency, increase productivity and enable better resource management. The main goal behind these strategies was to create the next generation digital infrastructure that would improve the delivery of services to citizens, from personalised administrative services to tailored health services, safer care for all and customised education. Some governments had started the transformation process. Then the pandemic changed everything. Almost overnight, governments were forced into a new reality that didn’t fit with mid- and long-term digital transformation objectives. Shutdowns changed the world from a largely in-person experience to a virtual experience for government workers and citizens. Government workforces had to quickly move entirely to remote working and governments had to adapt to find new ways to deliver services to citizens. Luckily, the availability of digital tools made the shift possible. So, while the pandemic continued to impact society, governments at all levels were able to shift operations and service delivery online.

whitePaper | July 18, 2022

The world is more peaceful, safe, and prosperous when the human rights of women are respected and they can fully participate in economic, social, and political life. But we know the enduring challenges of fulfilling that promise. A defining competition between democracies and autocracies. The COVID-19 pandemic. The climate crisis. Mass migration and displacement. The denial of education and sexual violence against women and girls across the world. No matter what global crisis unfolds—women and girls are disproportionately impacted, and that makes the world less stable.

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.